Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
Yahoo Finance - 2024-05-10T06:00:00.000Z

Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards Accelerates potential for development of a novel flu-COVID-19 combination product based on authorized vaccines with demonstrated efficacy and tolerability, potentially offering patients...

In related news

Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
- Related Articles
- In News
- From CNBC
- 2024-05-10T06:00:01.000Z
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Novavax agreed to license its vaccine technology to French drugmaker Sanofi to co-commercialize its COVID-19 vaccine, and also develop other vaccines.
- Related Articles
- In News
- From Investopedia
- 2024-05-10T14:50:05.784Z
People With More COVID-19 Vaccine Doses More Likely To Contract COVID-19: Study
People With More COVID-19 Vaccine Doses More Likely To Contract COVID-19: Study Authored by Zachary Stieber via The Epoch Times (emphasis ours), People who received more than one dose of a COVID-19 vaccine were more likely to contract COVID-19, according to a new study. A health care worker fills a syringe with Pfizer's COVID-19 vaccine in an undated file image. (Robyn Beck/AFP via Getty Images) An analysis of data from Cleveland Clinic employees found that people who received two...
- Related Articles
- In News
- From Zero Hedge
- 2024-05-04T02:20:00.000Z

In related news

Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots

Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines

People With More COVID-19 Vaccine Doses More Likely To Contract COVID-19: Study